baber/WOPTO huggingface dataset:
Patent AT-E248082-T1 (AT)
Inventor: LABRIE CRAIG B
IPC: B60K37/00
Filed: 1999-06-16
Granted: 2003-09-15
Abstract: An apparatus for deploying an air bag through an automotive dash panel (12) includes an air bag door (16) integrally formed in the panel and defined by a door perimeter including a frangible edge (18) of reduced cross section. A dispenser (20) supports the air bag (24) behind the door. A metal reaction plate (28) is positioned between the air bag (24) and the door (16). When the air bag inflates, it forces the reaction plate (28) to bend around a horizontal hinge line (36). As the reaction, plate pivots it concentrates inflation force along a lower portion of the frangible door edge. This helps to predictably separate the door from the dash panel by tearing along the lower door edge and allowing the tear to propagate up two side edges. In one embodiment, the tear also propagates across an upper edge to completely separate the door from the panel. At least one, and preferably two or three tethers (50) limit how far the door can travel during air bag inflation. A stop member may be included to limit reaction plate bending. After deployment, the reaction plate remains in a position that prevents the door from returning to its original position. A retaining structure may be included to preclude at least a portion of the air bag door from tearing free of the vehicle panel. A hinge (44) may be embedded in the panel in a position spanning a portion of the door perimeter. A hollow channel may be formed into the panel along the frangible marginal edge to create a substantial strength differential with the door perimeter to promote bending along the hinge and/or to help confine tearing to the frangible marginal edge during air bag deployment.
Patent AT-E274942-T1 (AT)
Inventor: WESTON TERENCE EDWARD
IPC: A61J1/00
Filed: 1999-09-01
Granted: 2004-09-15
Abstract: A needleless injector cartridge, comprises an injection component (1) defining a void (17) therein for receiving medicament, and having an injection discharge orifice communicating with the void. The cartridge further comprises a transfer device (2) comprising a liquid-containing reservoir (4), and transfer means for causing the liquid (5) to flow from the reservoir, through a reservoir outlet, into the void in the injection component.
Patent AT-E231873-T1 (AT)
Inventor: ANDRASI FERENC
IPC: C07D487/04
Filed: 1999-11-09
Granted: 2003-02-15
Abstract: Novel pyridazino[4,5-b][1,5]oxazepinone, thiazepinone and diazepinone derivatives of general formula (I) wherein: R stands for hydrogen atom or a group of formula NHR<4>, wherein: R<4> stands for hydrogen, C1-4 alkyl or C2-5 acyl group, R<1> stands for C1-4 alkyl or C2-4 alkenyl group, which may be substituted by a phenyl group, or phenyl group, W stands for methylene or carbonyl group, X and Y stand independently for oxygen or sulphur atom, SO, SO2 or NR<3> group, wherein R<3> is hydrogen atom, C1-4 alkyl group or a group of formula (II), wherein R<2> stands for hydrogen or halogen atom, C1-4 alkoxy or nitro group or a group of formula NHR<4>, wherein R<4> has the above meaning, and Z stands for methylene or carbonyl group, further n has a value of 0, 1 or 2, with the proviso that when any of X or Y stands for oxygen or sulphur atom, SO or SO2 group or a group of formula NR<3>, wherein R<3> stands for hydrogen atom or C1-4 alkyl group, then the other may stand only for an NR<3> group, wherein R<3> stands for a group of formula (II) - wherein R<2>, Z and n have the above meanings - and their tautomers and the acid-addition salts of all these compounds. The compounds according to the invention show memory-enhancing and neuroprotective properties.
Patent DE-10196388-T1 (DE)
Inventor: DATTA PAUL JOSEPH
IPC: A61F13/15
Filed: 2001-06-21
Abstract: A disposable absorbent underpants for containing body fluid includes a first pair of leg elastics, a second pair of leg elastics, and a third pair of leg elastics. Each of the third pair of leg elastics is a distinct member containing at least one strand of elastic that is partially enclosed by a carrier sheet. Each of the third pair of leg elastics is separated from at least one of the first or the second pair of leg elastics by a gap.
Patent DE-974343-T1 (DE)
Inventor: SETH PAWAN
IPC: A61K31/05
Filed: 1999-07-19
Abstract: A solid composition comprises: (a) 1-70 % metoprolol (M) in a non-amorphous form; (b) 10-95 % polyethylene oxide (PEO); and (c) a balance of conventional additives, excluding basic components. An Independent claim is also included for the preparation of the above composition, comprising: (i) mixing the dry state and the metoprolol (M) and the polyethylene oxide (PEO) and optionally one or more additives; (ii) optionally adding a solvent, followed by mixing; (iii) granulating the mixture; (iv) drying the granules; (v) optionally adding one or more additives with mixing in the dry state and passing it through a sieve; (vi) optionally adding one or more additives and mixing in the dry state; (vii) compressing the mixture obtained into a pressed tablet; and (viii) optionally coating the compressed tablet.
Patent DE-1096902-T1 (DE)
Inventor: DING NI
IPC: A61F2/82
Filed: 1999-07-06
Abstract: The medical devices of the invention comprise a portion having a porous surface for release of at least one biologically active agent therefrom. The porous surface is made of a material such as a polymer having a plurality of voids. To load the porous surface with a biologically active agent or drug, an electrophoresis method is employed. In this method, a device having a porous surface is placed into a drug solution or suspension, along with an electrode. An electric current is applied to the device and electrode. Under such a current, the drug, which has a positive or negative charge, will be loaded into the pores or voids of the porous surface.
Patent CY-1107560-T1 (CY)
Inventor: COHEN PAUL S
IPC: A61K39/108
Filed: 2007-02-21
Abstract: The present invention relates to live attenuated bacteria for use as a medicament. The invention also relates to vaccines based thereon that are useful for the prevention of microbial pathogenesis. Further, the invention relates to live attenuated recombinant bacteria carrying a heterologous gene and vaccines based thereon. Finally, the invention relates to methods for the preparation of such vaccines and bacteria.
Patent CY-1108115-T1 (CY)
Inventor: Aegir Björnsson
IPC: B01D27/04
Filed: 2008-06-05
Abstract: The present invention relates to a method for the production of liquid cleaners, consisting of a cleaner housing with a cleaning chamber exhibiting an inner and an outer end, and a cleaning insert arranged inside the cleaning chamber. The cleaner housing is given a conical shape such that the cleaning chamber receives a smaller lateral dimension at its inner end than at its outer end, said outer end being openable. The cleaning insert is manufactured from a fluid-permeable, compressible cleaning material with a lateral dimension that in an initial state, outside the cleaner housing, exceeds the smaller lateral dimension of the cleaning chamber. The other end of the cleaner housing is kept open, and the cleaning insert is inserted into said other end having the larger lateral dimension, and is pressed into the cleaning chamber towards the end having the smaller lateral dimension. Hereby, the cleaning insert is continuously compressed into receiving, at its inner end, said smaller lateral dimension, causing the cleaning material of cleaning insert to be gradually compacted, seen in the axial direction, at least in a portion at the inner end of the cleaner housing. The invention also relates to a liquid cleaner, produced by the method.
Patent CY-1110150-T1 (CY)
Inventor: PIRRI ROSANGELA
IPC: C08K9/04
Filed: 2010-06-30
Abstract: The present invention relates to hybrid impact modifiers prepared by: either spray drying, coagulation, freeze coagulation or other known recovery methods of a mixture of a latex or slurry of standard impact modifiers and a slurry of a mineral filler, or simultaneous drying (by spray-drying, coagulation other known recovery possible methods) of (i) a latex or slurry of standard impact modifiers and of (ii) a slurry of a mineral filler, further to the coagulation or freeze coagulation, if any, there is a filtration and drying step to recover these hybrid impact modifiers as a powder. The present invention also relates to the use of said hybrid impact modifiers in thermoplastic polymers, and a thermoplastic polymer containing said hybrid impact modifiers. The hybrid impact modifiers may exhibit improved powder properties (flowability, lumping/caking resistance, segregation between the organic and the mineral parts) and better dispersion homogeneities.
Patent CY-1111225-T1 (CY)
Title: Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c
Inventor: SAKSENA ANIL K
IPC: C07K5/065
Filed: 2010-09-01
Abstract: Η παρούσα εφεύρεση αποκαλύπτει νέες ενώσεις οι οποίες έχουν ανασταλτική δραστικότητα πρωτεάσης HCV καθώς και μεθόδους παρασκευής τέτοιων ενώσεων. Σε άλλη πραγματοποίηση η εφεύρεση αποκαλύπτει φαρμακευτικές συνθέσεις που περιλαμβάνουν τέτοιες ενώσεις, καθώς και μεθόδους χρήσης αυτών για την θεραπεία διαταραχών που σχετίζονται με την πρωτεάση HCV.
Patent CY-1112472-T1 (CY)
Inventor: GREINER DAN
IPC: G06F9/445
Filed: 2011-10-11
Abstract: A facility and cache machine instruction of a computer architecture for specifying a target cache cache-level and a target cache attribute of interest for obtaining a cache attribute of one or more target caches. The requested cache attribute of the target cache(s) is saved in a register.
Patent CY-1113766-T1 (CY)
Title: Παραγωγα ινδολιδονης για την θεραπεια ή προληψη ινωτικων ασθενειων
Inventor: PARK JOHN EDWARD
IPC: A61K31/496
Filed: 2013-01-30
Abstract: Η παρούσα εφεύρεση αφορά στην χρήση ινδολινονών του γενικού τύπου (I) υποκατεστημένων στην 6 θέση, όπου τα R1 έως R5 και το Χ ορίζονται όπως στην αξίωση 1, τα ισομερή και τα άλατα αυτών, ιδιαιτέρως τα φυσιολογικώς αποδεκτά άλατα αυτών, ως φάρμακο για την πρόληψη ή θεραπεία συγκεκριμένων ινωτικών ασθενειών.
Patent CY-1117981-T1 (CY)
Title: Μεθοδος και συσκευη για κωδικοποιηση / αποκωδικοποιηση εντροπιας ενος συντελεστη μετασχηματισμου
Inventor: LEE BAE-KEUN
IPC: H04N19/176
Filed: 2016-09-07
Abstract: Μια μέθοδος και μια συσκευή για κωδικοποίηση και αποκωδικοποίηση εντροπίας ενός μπλοκ μετασχηματισμού. Η μέθοδος κωδικοποίησης εντροπίας ενός μπλοκ μετασχηματισμού περιλαμβάνει τον προσδιορισμό μιας τοποθεσίας ενός τελευταίου σημαντικού συντελεστή μετασχηματισμού που έχει μια μη μηδενική τιμή μεταξύ των συντελεστών μετασχηματισμού που περιλαμβάνονται σε ένα μπλοκ μετασχηματισμού που έχει ένα ορισμένο μέγεθος, σύμφωνα με μια ορισμένη σειρά σάρωσης και κωδικοποίηση πληροφοριών σχετικά με την τοποθεσία του τελευταίου σημαντικού συντελεστή μετασχηματισμού, χρησιμοποιώντας την τοποθεσία κατεύθυνσης του οριζόντιου άξονα και την τοποθεσία κατεύθυνσης κατακόρυφου άξονα στο μπλοκ μετασχηματισμού.
Patent CY-1123100-T1 (CY)
Title: Μεθοδος για την παρασκευη amg 416
Inventor: BEZEMER JEROEN
IPC: C07K7/06
Filed: 2020-04-29
Abstract: Παρέχεται μια μέθοδος για την παρασκευή του AMG 416, ή ενός φαρμακευτικώς αποδεκτού άλατος αυτού. To AMG 416 είναι ένας συνθετικός, επιλεκτικός πεπτιδικός αγωνιστής οκτώ αμινοξέων του υποδοχέα ανίχνευσης ασβεστίου. Αναπτύσσεται ως ενδοφλέβια αγωγή του δευτεροπαθούς υπερπαραθυρεοειδισμού (SHPT) σε ασθενείς που υπόκεινται σε αιμοκάθαρση με χρόνια νεφρική νόσο - διαταραχή οστών και μετάλλων (CKD-MBD).
Patent CY-1123287-T1 (CY)
Title: Αναλυση γονιδιωματικων κλασματων με χρηση των αριθμων πολυμορφισμων
Inventor: RAVA RICHARD P
IPC: C12Q1/68
Filed: 2020-08-27
Abstract: Αποκαλύπτονται μέθοδοι αξιόπιστης εκτίμησης γονιδιωματικού κλάσματος (π.χ., εμβρυϊκού κλάσματος} από πολυμορφισμούς όπως μικρές παραλλαγές βάσης ή προσθήκες-απαλοιφές. Χρησιμοποιούνται δεδομένα από μία πολυγονιδιωματική πηγή τα οποία έχουν υποβληθεί σε ανάλυση αλληλουχίας, ώστε να καθορισθούν οι αριθμοί αλληλομόρφου για έναν ή περισσότερους από τους πολυμορφισμούς. Για έναν ή περισσότερους από τους πολυμορφισμούς, χαρακτηρίζεται η ζυγωτία και το γονιδιακό κλάσμα ορίζεται από τους αριθμούς ζυγωτίας και αλληλομόρφου. Συγκεκριμένες υλοποιήσεις χρησιμοποιούν SNPs ως τον σχετικό πολυμορφισμό. Οι αποκαλυπτόμενες μέθοδοι μπορούν να εφαρμοσθούν ως ένα τμήμα μιας σκόπιμης προσχεδιασμένης μελέτης επαναλαμβανόμενης ανάλυσης αλληλουχίας η οποία στοχεύει έναντι γνωστών πολυμορφισμών ή μπορούν να χρησιμοποιηθούν σε μία αναδρομική ανάλυση παραλλαγών οι οποίες ευρίσκονται συμπτωματικά σε επικαλυπτόμενες αλληλουχίες οι οποίες δημιουργούνται από μητρικό πλάσμα (ή οποιαδήποτε άλλη διάταξη όπου υπάρχει ένα μίγμα DNA από περισσότερα άτομα).
Patent CY-1124074-T1 (CY)
Title: Φαρμακευτικες συνθεσεις για θεραπεια υποκαταστασης γλυκοκορτικοειδων
Inventor: SKRTIC STANKO
IPC: A61K9/20
Filed: 2021-03-05
Abstract: Η εφεύρεση σχετίζεται με θεραπεία υποκατάστασης γλυκοκορτικοειδών και παρέχει φαρμακευτικές συνθέσεις και κιτ σχεδιασμένα για την παροχή ενός ή περισσοτέρων γλυκοκορτικοειδών σε έναν ασθενή με ανάγκη αυτών με έναν τρόπο που έχει ως αποτέλεσμα επίπεδα ορού του γλυκοκορτικοειδούς που ουσιαστικά μιμούνται εκείνο ενός υγιούς ατόμου για μία κλινικώς ενδεδειγμένη χρονική περίοδο. Η φαρμακευτική σύνθεση περιλαμβάνει ένα ή περισσότερα γλυκοκορτικοειδή, όπου ένα πρώτο τμήμα ενός ή περισσοτέρων γλυκοκορτικοειδών απελευθερώνεται ουσιαστικά άμεσα και ένα δεύτερο τμήμα ενός ή περισσοτέρων γλυκοκορτικοειδών απελευθερώνεται επί ένα παρατεταμένο χρονικό διάστημα τουλάχιστον περίπου 8 ωρών, και η ποσότητα του ενός ή περισσοτέρων γλυκοκορτικοειδών του πρώτου τμήματος, εκφραζόμενα ως ισοδύναμα υδροκορτιζόνης, είναι σε ένα διάστημα από περίπου 15 έως περίπου 50% των συνολικών ισοδυνάμων υδροκορτιζόνης. Η εφεύρεση επίσης σχετίζεται με ένα κιτ που περιλαμβάνει ένα πρώτο και ένα δεύτερο συστατικό, όπου το πρώτο συστατικό είναι σχεδιασμένο για να απελευθερώνει ένα ή περισσότερα γλυκοκορτικοειδή ουσιαστικά άμεσα και το δεύτερο συστατικό είναι σχεδιασμένο για να απελευθερώνει ένα ή περισσότερα γλυκοκορτικοειδή επί ένα παρατεταμένο χρονικό διάστημα τουλάχιστον 8 ωρών. Η εφεύρεση επίσης σχετίζεται με μία μέθοδο αγωγής νόσων που απαιτούν αγωγή με γλυκοκορτικοειδή όπως σε ασθενείς που έχουν μία διαταραχή ανεπάρκειας γλυκοκορτικοειδών. Σε μία άλλη άποψη, η εφεύρεση σχετίζεται με τη χρήση μίας πρώτης και μίας δεύτερης ποσότητας ενός ή περισσοτέρων γλυκοκορτικοειδών για την παρασκευή μίας φαρμακευτικής σύνθεσης ή κιτ για την αγωγή μίας διαταραχής ανεπάρκειας γλυκοκορτικοειδών.
Patent CY-1124211-T1 (CY)
Title: Πλατφορμα για την εξορυξη πετρελαιου
Inventor: KOCH CHRISTIAN
IPC: E21B43/34
Filed: 2021-05-31
Abstract: Μια πλατφόρμα για την εξόρυξη πετρελαίου με ένα σώμα βάσης, που αποτελείται από μια εγκατάσταση εξόρυξης πετρελαίου, και με μια δομή στήριξης για το σώμα βάσης, χαρακτηρίζεται από το ότι το σώμα βάσης περιλαμβάνει επιπροσθέτως ένα διυλιστήριο πετρελαίου.
Patent CY-1126073-T1 (CY)
Title: Idhp για χρηση στην θεραπευτικη αναστολη σχηματισμου αιμοπεταλιων, στην θεραπευτικη υποκινηση αγγειογενεσης και στην αποτροπη ή θεραπεια αγγειακης ανοιας
Inventor: ZHENG XIAOHUI
IPC: A61K31/216
Filed: 2023-06-13
Abstract: Χρήση β-(3,4-διυδροξυφαινυλ)-α-υδροξυπροπιονικού ισοπροπύλ εστέρα (IDHP) στην παρασκευή ενός φαρμάκου ή προϊόντος υγείας για αποτροπή και θεραπεία ασθενειών αθηροσκλήρωσης της στεφανιαίας. Ο IDHP μπορεί επίσης να χρησιμοποιηθεί για να παρεμποδίσει συσσωμάτωση αιμοπεταλίου, να υποκινήσει αγγειογένεση, και για να παρασκευάσει ένα φάρμακο και ένα προϊόν υγείας για αποτροπή και θεραπεία γεροντικής αγγειακής άνοιας.
Patent HR-P20100700-T1 (HR)
Inventor: CALVO RAUL L
IPC: A61K31/4184
Filed: 2010-12-17
Abstract: Spoj formule (I): i njegov oblik, naznačen time, dacrtkane linije između pozicija 1, 2 i 3 u formuli (I) označavaju pozicije tautomerne duple veze, pri čemu kada je dupla veza oblikovana između pozicija 1 i 2, tada je prisutan R3b, i pri čemu kada je dupla veza oblikovana između pozicija 2 i 3, tada je prisutan R3a;p je 1 ili 2; q je 0 ili 1; r je 0, 1, 2 ili 3; L je C1-3alkil, C2-3alkenil, C2-3alkinil ili ciklopropil; A1 je odabran iz skupine koja sadrži fenil, bifenil, naftil, piridinil, kinolinil i indol; R1 je svaki odabran iz skupine koja sadrži hidroksi, cijano, halogen, formil, karboksi, C1-6alkil, haloC1-6alkil,
Patent SI-1233012-T1 (SI)
Title: Method for producing phthalic anhydride according to specifications
Inventor: DISTELDORF WALTER DR
IPC: C07C63/00
Filed: 2001-02-12
Abstract: Production of marketable-grade phthalic anhydride such that the column is operated at a specified reflux ratio. Production of marketable-grade phthalic anhydride by distillation of crude anhydride in a reduced pressure column, with removal of the low boilers at or near the top and of the desired product at a side point, is such that the column is operated at a reflux ratio x of 1 : 1.7-3.
Patent SI-1420195-T1 (SI)
Title: Continuously variable ratio drive
Inventor: DOVERI STEFANO
IPC: F16H55/32
Filed: 2003-06-30
Abstract: A continuously variable ratio drive of the type with expandable conical pulleys for internal combustion engines comprising a pair of pulleys, one being a drive pulley and the other being a driven pulley, between which a transmission belt (31) slides, the drive pulley (32) in turn comprising an axially mobile element (32'), and a fixed element (32'') both in the form of frusto-conical discs facing towards each other so as to constitute a groove in which the belt (31) slides, the mobile element (32') being operatively connected to an electric motor (61) driven and controlled by an electronic unit and suitable for causing the axial movement of the mobile element (32') through engagement of cylindrical pins (37), housed in holes formed in an outer bush (47) placed in rotation by the electric motor (61), in helical slots (40) formed in an inner bush (38) bound axially to the outside of the mobile element (32') <IMAGE>
Patent SI-1467268-T1 (SI)
Title: Decoder for watering system
Inventor: BRUNDISINI ANDREA
IPC: G05B19/00
Filed: 2004-04-05
Abstract: A decoder is described that comprises first terminals (21a, 21b) suitable to receive a codified start signal (31) coming from a control unit (9), means (32) for decoding the start signal, programmable controller means (34, 50) provided with memory and startable by the decoded start signal (33), signal generating means (51, 52) controlled by said controller means (34, 50) in such a way so as to generate a control signal (60) in alternate current in order to turn on and off at least one solenoid in alternate current (15,..., 17) for the operation of a solenoid valve. The control signal (60) comprises an initial pulse (70) for the start of the solenoid and a plurality of pulses (71) with prefixed cadence for the maintenance of the solenoid in the ON state. The initial start pulse (70) has a certain voltage value (V1) and a certain duration (T1) and each one of said maintenance pulses (71) has equal voltage value but duration (T2) shorter than said start pulse (70). The programmable controller means (50) control said signal generating means (51, 52) so that the control signal (60) provides the repetition of said initial start pulse (70) and said maintenance pulses (71) with prefixed cadence (T) for a predetermined number of times.
Patent SI-1753824-T1 (SI)
Title: Stable liquid formulations of anionic dyes
Inventor: BERENGUER JORDI
IPC: C09B67/26
Filed: 2005-05-12
Abstract: The present invention concerns concentrated aqueous solutions of anionic disazo dyes, comprising salts and or the free acids of anionic dyes of the formula and 2-(2-butoxyethoxy) ethanol wherein the substituents are each as defined in claim 1 and the use of these solutions for dyeing and/or printing hydroxyl-containing substrates and for producing inkjet inks.
Patent SI-2144752-T1 (SI)
Title: Sealable, peelable film
Inventor: HEWITT JONATHAN
IPC: B65D65/00
Filed: 2008-05-02
Abstract: A sealable and peelable film comprising a four layer coextrudate comprising a core layer contributing predominantly towards the thickness of the film, a first sealing layer provided on one side of the core layer and a second sealing layer, or alternatively a laminating layer, provided on the other side of the core layer, and the film comprising a peeling layer in between the first sealing layer and the core layer and/or in between the second sealing layer, or alternatively the laminating layer, and the core layer, and wherein the peeling layer is adjacent the first sealing layer and/or the second sealing layer and/or the laminating layer, and wherein the relative thickness of the peeling layer and its adjacent sealing and/or lamination layer (p:s/l ratio) is from 1:10 to 5:1.
Patent SI-2432144-T1 (SI)
Title: Apparatus for transmitting and receiving a signal and method of transmitting and receiving a signal
Inventor: KO WOO SUK
IPC: H04L27/00
Filed: 2009-06-03
Abstract: The present invention relates to method of transmitting and receiving signals and a corresponding apparatus. One aspect of the present invention relates to a method of receiving a signal, which includes a L1 scheduling structure for reduced overhead in the FECFRAME headers.
Patent SI-2797950-T1 (SI)
Title: Anticancer fusion protein
Inventor: PIECZYKOLAN JERZY SZCZEPAN
IPC: C12N9/00
Filed: 2012-12-22
Abstract: A fusion protein comprising domain (a) which is a functional fragment of hTRAIL protein sequence, which fragment begins with an amino acid at a position not lower than hTRAIL95, or a homolog of said functional fragment having at least 70% sequence identity, preferably 85% identity and ending with the amino acid hTRAIL281; and at least one domain (b) which is a sequence of a cytolytic effector peptide forming pores in the cell membrane, wherein the sequence of domain (b) is attached at the C-terminus or N-terminus of domain (a).The fusion protein can be used for the treatment of cancer diseases.
Patent TR-200001043-T1 (TR)
Title: Heterofaz polimer bileşimlerinin üretimi için yöntem, ve bu şekilde elde edilen bileşimler.
Inventor: GOVONI GABRIELE
IPC: C08F4/622
Filed: 1999-08-03
Abstract: Heterofaz poliolefin bilesimleri hazirlamak için asagidakileri içeren bir islemdir: i) asagidakileri içeren bir safha, a) bir kristal propilen veya etilen polimer olusturmak için propilenin polimerizasyonu, ve b) bir C3-C10 alfa-olefin ile etilenin, bir elastomerik kopolimer olusturmak için, kopolimerizasyonu; bahsedilen safha bir Ziegler-Natta katalizörü varliginda gerçeklestirilir; ii) (i) polimerizasyon safhasinda elde edilen polimerin asagidakiler ile temas ettirildigi bir isleme safhasi: a) bahsedilen i) safhasinda mevcut olan katalizörün aktifligini giderebilen bir bilesik; ve b) (l) bir geçis metali, ve bir pi-bagi tarafindan metal M ile koordineli en az bir ligant içeren bir bilesik ve (II) bir yardimci katalizör eklenerek elde edilen bir katalizör (2); iii) safha (ii)'de islenmis olan bir polimerin  ve bahsedilen katalizörün (2) varliginda etilen ve C3-C10 alfa-olefinin polimerize edildigi kopolimerizasyon safhasi.
Patent DE-3486208-T2 (DE)
Inventor: DEMAREST HENRY MARTIN
IPC: C03B5/235
Filed: 1984-07-06
Granted: 1994-02-03
Abstract: Liquefying of pulverulent batch materials (e.g., glass batch) is carried out in two stages. The first stage (10) utilizes extended gas/solid contact to heat the materials to an intermediate temperature, and may recover waste heat. The second stage (12) rapidly liquefies the material in a cavity lined with the batch material, and may employ substantially nitrogen-free heat sources. Another aspect involves maintaining a wet condition in the first stage to entrap particulates.
Patent DE-3650328-T2 (DE)
Inventor: NAKAMURA HIDEO
IPC: C21C7/00
Filed: 1986-12-18
Granted: 1996-01-11
Abstract: A method and an apparatus, wherein heat can be effectively transferred to molten metal (12) contained in a reaction vessel. The pressure of gaseous atmosphere (16) within the vessel is maintained higher than atmospheric pressure. Oxygen gas is blown to a layer (14) of molten slag contained in the vessel through tuyeres set in the reaction vessel, thereby to achieve post-combustion therein. The pressure in the vessel is controlled within the range of 2.0 to 5.0 kg/cm<sup>2</sup> by pressure regulator (26).